Adeno-associated virus type 2 vectors: Transduction and long-term expression in cerebellar Purkinje cells in vivo is mediated by the fibroblast growth factor receptor 1: bFGFR-1 mediates AAV2 transduction of Purkinje cells

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The receptor for adeno-associated virus serotype 2 (AAV2) in Purkinje cells has not been identified, but based on work carried out in non-neuronal cell lines, heparan sulfate proteoglycan is thought to act as a primary receptor, with basic fibroblast growth factor receptor-1 being reported as a co-receptor. In this study, using antibody interference and protein competition strategies, we show specific reduction in Purkinje cell transduction by AAV2 vector in the presence of these inhibitors. We also demonstrate AAV2-mediated transgene expression in Purkinje cells in vivo that extends out to one year post-injection. These results provide new information on fibroblast growth factor receptor-1 involvement in AAV2-mediated transduction of Purkinje cells and have important implications for AAV-mediated treatment of various cerebellar disorders.

Original languageEnglish (US)
Pages (from-to)2107-2110
Number of pages4
JournalArchives of Virology
Volume153
Issue number11
DOIs
StatePublished - Nov 1 2008

Fingerprint

Receptor, Fibroblast Growth Factor, Type 1
Dependovirus
Purkinje Cells
Cerebellar Diseases
Heparan Sulfate Proteoglycans
Fibroblast Growth Factor 2
Transgenes
Cell Line
Injections
Serogroup
Antibodies
Proteins

Cite this

@article{63750ef6a2694073a2ddd4bb006e55ea,
title = "Adeno-associated virus type 2 vectors: Transduction and long-term expression in cerebellar Purkinje cells in vivo is mediated by the fibroblast growth factor receptor 1: bFGFR-1 mediates AAV2 transduction of Purkinje cells",
abstract = "The receptor for adeno-associated virus serotype 2 (AAV2) in Purkinje cells has not been identified, but based on work carried out in non-neuronal cell lines, heparan sulfate proteoglycan is thought to act as a primary receptor, with basic fibroblast growth factor receptor-1 being reported as a co-receptor. In this study, using antibody interference and protein competition strategies, we show specific reduction in Purkinje cell transduction by AAV2 vector in the presence of these inhibitors. We also demonstrate AAV2-mediated transgene expression in Purkinje cells in vivo that extends out to one year post-injection. These results provide new information on fibroblast growth factor receptor-1 involvement in AAV2-mediated transduction of Purkinje cells and have important implications for AAV-mediated treatment of various cerebellar disorders.",
author = "Belur, {Lalitha R.} and Kaemmerer, {William F.} and McIvor, {R. Scott} and Low, {Walter C.}",
year = "2008",
month = "11",
day = "1",
doi = "10.1007/s00705-008-0222-7",
language = "English (US)",
volume = "153",
pages = "2107--2110",
journal = "Archives of Virology",
issn = "0304-8608",
publisher = "Springer Wien",
number = "11",

}

TY - JOUR

T1 - Adeno-associated virus type 2 vectors

T2 - Transduction and long-term expression in cerebellar Purkinje cells in vivo is mediated by the fibroblast growth factor receptor 1: bFGFR-1 mediates AAV2 transduction of Purkinje cells

AU - Belur, Lalitha R.

AU - Kaemmerer, William F.

AU - McIvor, R. Scott

AU - Low, Walter C.

PY - 2008/11/1

Y1 - 2008/11/1

N2 - The receptor for adeno-associated virus serotype 2 (AAV2) in Purkinje cells has not been identified, but based on work carried out in non-neuronal cell lines, heparan sulfate proteoglycan is thought to act as a primary receptor, with basic fibroblast growth factor receptor-1 being reported as a co-receptor. In this study, using antibody interference and protein competition strategies, we show specific reduction in Purkinje cell transduction by AAV2 vector in the presence of these inhibitors. We also demonstrate AAV2-mediated transgene expression in Purkinje cells in vivo that extends out to one year post-injection. These results provide new information on fibroblast growth factor receptor-1 involvement in AAV2-mediated transduction of Purkinje cells and have important implications for AAV-mediated treatment of various cerebellar disorders.

AB - The receptor for adeno-associated virus serotype 2 (AAV2) in Purkinje cells has not been identified, but based on work carried out in non-neuronal cell lines, heparan sulfate proteoglycan is thought to act as a primary receptor, with basic fibroblast growth factor receptor-1 being reported as a co-receptor. In this study, using antibody interference and protein competition strategies, we show specific reduction in Purkinje cell transduction by AAV2 vector in the presence of these inhibitors. We also demonstrate AAV2-mediated transgene expression in Purkinje cells in vivo that extends out to one year post-injection. These results provide new information on fibroblast growth factor receptor-1 involvement in AAV2-mediated transduction of Purkinje cells and have important implications for AAV-mediated treatment of various cerebellar disorders.

UR - http://www.scopus.com/inward/record.url?scp=55949122206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55949122206&partnerID=8YFLogxK

U2 - 10.1007/s00705-008-0222-7

DO - 10.1007/s00705-008-0222-7

M3 - Article

C2 - 18937030

AN - SCOPUS:55949122206

VL - 153

SP - 2107

EP - 2110

JO - Archives of Virology

JF - Archives of Virology

SN - 0304-8608

IS - 11

ER -